These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7543094)
1. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. Taylor AH; Heavner G; Nedelman M; Sherris D; Brunt E; Knight D; Ghrayeb J J Biol Chem; 1995 Jul; 270(30):17934-8. PubMed ID: 7543094 [TBL] [Abstract][Full Text] [Related]
2. Glucose phosphorylated on carbon 6 suppresses lipopolysaccharide binding to lipopolysaccharide-binding protein and inhibits its bioactivities. Fujita Y; Yagi K Int Immunopharmacol; 2017 Apr; 45():43-52. PubMed ID: 28187312 [TBL] [Abstract][Full Text] [Related]
3. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation. Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398 [TBL] [Abstract][Full Text] [Related]
4. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. Theofan G; Horwitz AH; Williams RE; Liu PS; Chan I; Birr C; Carroll SF; Mészáros K; Parent JB; Kasler H J Immunol; 1994 Apr; 152(7):3623-9. PubMed ID: 7511654 [TBL] [Abstract][Full Text] [Related]
5. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748 [TBL] [Abstract][Full Text] [Related]
6. Natural and synthetic polypeptides that recognize the conserved lipid a binding site of lipopolysaccharides. Porro M; Rustici A; Velucchi M; Agnello D; Villa P; Ghezzi P Prog Clin Biol Res; 1998; 397():315-25. PubMed ID: 9575572 [No Abstract] [Full Text] [Related]
7. Heat shock protein 60: specific binding of lipopolysaccharide. Habich C; Kempe K; van der Zee R; Rümenapf R; Akiyama H; Kolb H; Burkart V J Immunol; 2005 Feb; 174(3):1298-305. PubMed ID: 15661886 [TBL] [Abstract][Full Text] [Related]
8. Cyclic Limulus anti-lipopolysaccharide (LPS) factor-derived peptide CLP-19 antagonizes LPS function by blocking binding to LPS binding protein. Liu Y; Ni B; Ren JD; Chen JH; Tian ZQ; Tang M; Li D; Xia P Biol Pharm Bull; 2011; 34(11):1678-83. PubMed ID: 22040879 [TBL] [Abstract][Full Text] [Related]
9. The localization of two mimic epitopes of lipopolysaccharide binding protein and the preparation of their tandem multiple antigen peptide. Feng YK; Yang QH; Liu YS; Xu JC; Qian GS; Wang YH J Immunol Methods; 2010 Oct; 362(1-2):60-9. PubMed ID: 20833181 [TBL] [Abstract][Full Text] [Related]
10. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library. Reyes O; Vallespi MG; Garay HE; Cruz LJ; González LJ; Chinea G; Buurman W; Araña MJ J Pept Sci; 2002 Apr; 8(4):144-50. PubMed ID: 11991204 [TBL] [Abstract][Full Text] [Related]
11. Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro. Xu Z; Qian GS; Li Q; Feng QJ; Wu GM; Li KL Inflamm Res; 2009 Jan; 58(1):45-53. PubMed ID: 19115038 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli. Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777 [TBL] [Abstract][Full Text] [Related]
14. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii. Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. Gupta H; Dai L; Datta G; Garber DW; Grenett H; Li Y; Mishra V; Palgunachari MN; Handattu S; Gianturco SH; Bradley WA; Anantharamaiah GM; White CR Circ Res; 2005 Aug; 97(3):236-43. PubMed ID: 16002747 [TBL] [Abstract][Full Text] [Related]
17. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Rustici A; Velucchi M; Faggioni R; Sironi M; Ghezzi P; Quataert S; Green B; Porro M Science; 1993 Jan; 259(5093):361-5. PubMed ID: 8420003 [TBL] [Abstract][Full Text] [Related]
18. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. Rosenfeld Y; Papo N; Shai Y J Biol Chem; 2006 Jan; 281(3):1636-43. PubMed ID: 16293630 [TBL] [Abstract][Full Text] [Related]
19. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo. Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530 [TBL] [Abstract][Full Text] [Related]
20. The lipopolysaccharide from Capnocytophaga canimorsus reveals an unexpected role of the core-oligosaccharide in MD-2 binding. Ittig S; Lindner B; Stenta M; Manfredi P; Zdorovenko E; Knirel YA; dal Peraro M; Cornelis GR; Zähringer U PLoS Pathog; 2012; 8(5):e1002667. PubMed ID: 22570611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]